Mark O Goodarzi Selected Research

Mark O Goodarzi Research Topics

Disease

47	Insulin Resistance 07/2022 - 06/2003
35	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2005
27	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2020 - 01/2005
17	Obesity 01/2022 - 06/2003
12	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2004
11	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 07/2003
9	Atherosclerosis 01/2018 - 04/2005
4	Breast Neoplasms (Breast Cancer) 03/2022 - 07/2012
4	Inflammation (Inflammations) 01/2020 - 08/2013
4	Hyperandrogenism 12/2018 - 04/2011
4	Hypertension (High Blood Pressure) 11/2017 - 04/2011
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2019
3	Chronic Pancreatitis 01/2022 - 01/2021
3	Coronary Disease (Coronary Heart Disease) 01/2022 - 01/2016
3	Infertility (Sterility) 01/2019 - 11/2016
3	Diabetes Mellitus 01/2019 - 08/2005
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017 - 04/2011
3	Neoplasms (Cancer) 10/2016 - 03/2011
2	Prediabetic State (Prediabetes) 07/2022 - 07/2010
2	Lipodystrophy 01/2022 - 01/2020
2	Non-alcoholic Fatty Liver Disease 01/2019 - 11/2010
2	Hyperinsulinism (Hyperinsulinemia) 11/2017 - 04/2011
2	Diabetic Retinopathy (Retinopathy, Diabetic) 09/2015 - 01/2014
2	Hyperplasia 01/2015 - 01/2003
2	Glucose Intolerance 07/2010 - 08/2005
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Stroke (Strokes) 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Adenocarcinoma 01/2022
1	Critical Illness (Critically Ill) 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	COVID-19 01/2021
1	Malnutrition (Nutritional Deficiencies) 01/2020
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020
1	Pancreatic Diseases (Pancreatic Disease) 01/2020
1	Genetic Risk Score 01/2020
1	Disease Progression 01/2020
1	Overweight 12/2019

Drug/Important Bio-Agent (IBA)

43	Insulin (Novolin)FDA Link 07/2022 - 01/2004
42	Glucose (Dextrose)FDA LinkGeneric 07/2022 - 01/2004
16	AndrogensIBA 02/2016 - 01/2003
12	LipidsIBA 01/2022 - 06/2003
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2008
6	Testosterone (Sustanon)FDA Link 01/2022 - 01/2003
6	EnzymesIBA 01/2022 - 07/2007
5	LDL CholesterolIBA 01/2022 - 11/2013
5	AdiponectinIBA 08/2020 - 04/2011
4	GonadotropinsIBA 01/2020 - 08/2015
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2016
4	SteroidsIBA 01/2019 - 04/2007
4	Hormones (Hormone)IBA 01/2019 - 04/2007
4	Blood Glucose (Blood Sugar)IBA 04/2015 - 08/2005
4	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2007 - 07/2003
3	Sex Hormone-Binding GlobulinIBA 01/2022 - 04/2011
3	oxidized low density lipoproteinIBA 01/2020 - 01/2017
3	Transcription Factors (Transcription Factor)IBA 12/2019 - 01/2008
3	Pharmaceutical PreparationsIBA 01/2017 - 01/2016
3	Androgen Receptors (Androgen Receptor)IBA 02/2016 - 05/2008
3	CholesterolIBA 10/2015 - 08/2005
3	Triglycerides (Triacylglycerol)IBA 04/2015 - 11/2013
3	Metformin (Glucophage)FDA LinkGeneric 06/2014 - 11/2005
3	Dehydroepiandrosterone SulfateIBA 07/2008 - 12/2006
2	Estrogen ReceptorsIBA 01/2022 - 11/2017
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2021 - 01/2018
2	C-Reactive ProteinIBA 08/2020 - 01/2013
2	Plasminogen Activator Inhibitor 1IBA 08/2020 - 01/2013
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 01/2017
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019 - 11/2005
2	Lipoproteins (Lipoprotein)IBA 12/2017 - 11/2013
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2017 - 11/2010
2	Hemoglobins (Hemoglobin)IBA 09/2017 - 04/2015
2	Insulin-Like Growth Factor I (IGF-1)IBA 10/2016 - 03/2011
2	AcetyltransferasesIBA 01/2016 - 04/2015
2	Genetic Markers (Genetic Marker)IBA 12/2015 - 06/2004
2	Caveolin 1IBA 12/2015 - 08/2011
2	DNA (Deoxyribonucleic Acid)IBA 10/2015 - 07/2010
2	Biological ProductsIBA 09/2015 - 04/2008
2	Insulin ReceptorIBA 08/2015 - 04/2011
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2015 - 04/2007
2	CatecholaminesIBA 06/2014 - 12/2010
2	HDL CholesterolIBA 11/2013 - 04/2013
2	Glycogen Synthase KinasesIBA 04/2011 - 06/2007
2	3 (or 17)-beta-hydroxysteroid dehydrogenaseIBA 12/2009 - 01/2008
2	Glycogen Synthase Kinase 3 betaIBA 12/2008 - 06/2007
2	Dehydroepiandrosterone (DHEA)IBA 07/2007 - 04/2007
1	AntioxidantsIBA 03/2022
1	NucleotidesIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	ProinsulinIBA 01/2022
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2021
1	Plasminogen Activators (Plasminogen Activator)IBA 08/2020
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2020
1	Long Noncoding RNAIBA 01/2020
1	Benzoates (Benzoate)IBA 01/2019
1	Mitochondrial DNA (mtDNA)IBA 01/2019
1	XanthineIBA 01/2019

Therapy/Procedure

2	Glycemic Control 01/2022 - 09/2017
2	Therapeutics 01/2017 - 11/2005
1	Dietary Approaches To Stop Hypertension 01/2022